Hewlett Packard Enterprise vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 78)

Hewlett Packard Enterprise

LeaderConsumer Technology

Enterprise

Enterprise IT infrastructure with $31.8B FY2024 revenue; $14B Juniper Networks acquisition (pending 2025); GreenLake as-a-service; AI server surge beneficiary with Cray and ProLiant GPU lines.

AI VisibilityBeta
Overall Score
B78
Category Rank
#32 of 290
AI Consensus
90%
Trend
stable
Per Platform
ChatGPT
70
Perplexity
71
Gemini
71

About

Hewlett Packard Enterprise (HPE) is a global enterprise IT infrastructure company spun off from Hewlett-Packard in November 2015, headquartered in Spring, Texas and trading on NYSE (HPE). The company reported $31.8 billion in revenues for fiscal year 2024 (ending October 31) under CEO Antonio Neri, spanning servers, storage, networking, and hybrid cloud services. HPE's most significant strategic move of the decade is its pending $14 billion acquisition of Juniper Networks—announced January 2024 and under regulatory review through 2025—which would combine HPE's ProLiant server and Aruba networking portfolios with Juniper's AI-native networking platform, Mist AI, creating a more complete enterprise infrastructure competitor to Cisco.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

78
Overall Score
90
#32
Category Rank
#9
90
AI Consensus
60
stable
Trend
stable
70
ChatGPT
99
71
Perplexity
99
71
Gemini
83
70
Claude
96
74
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.